These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23183589)

  • 1. Effect of white matter lesions on brain perfusion in Alzheimer's disease.
    Kimura N; Nakama H; Nakamura K; Aso Y; Kumamoto T
    Dement Geriatr Cogn Disord; 2012; 34(3-4):256-61. PubMed ID: 23183589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between white matter lesions and regional cerebral blood flow changes during longitudinal follow up in Alzheimer's disease.
    Hanaoka T; Kimura N; Aso Y; Takemaru M; Kimura Y; Ishibashi M; Matsubara E
    Geriatr Gerontol Int; 2016 Jul; 16(7):836-42. PubMed ID: 26245516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of white matter lesions on brain perfusion in patients with mild cognitive impairment.
    Ishibashi M; Kimura N; Aso Y; Matsubara E
    Clin Neurol Neurosurg; 2018 May; 168():7-11. PubMed ID: 29499394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voxel-based comparison of rCBF SPET images in frontotemporal dementia and Alzheimer's disease highlights the involvement of different cortical networks.
    Varrone A; Pappatà S; Caracò C; Soricelli A; Milan G; Quarantelli M; Alfano B; Postiglione A; Salvatore M
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1447-54. PubMed ID: 12397463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
    Nakano S; Asada T; Matsuda H; Uno M; Takasaki M
    J Nucl Med; 2001 Oct; 42(10):1441-5. PubMed ID: 11585854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of regional cerebral blood flow in Alzheimer's disease patients with subclinical hypothyroidism.
    Haji M; Kimura N; Hanaoka T; Aso Y; Takemaru M; Hirano T; Matsubara E
    Dement Geriatr Cogn Disord; 2015; 39(5-6):360-7. PubMed ID: 25895684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic deterioration of ADAS-Jcog subscale scores and correlations with regional cerebral blood flow reductions in Alzheimer's disease.
    Yoshii F; Kawaguchi C; Kohara S; Shimizu M; Onaka H; Ryo M; Takahashi W
    Neurol Sci; 2018 May; 39(5):909-918. PubMed ID: 29508099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
    Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
    Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
    J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    Tai H; Hirano S; Sakurai T; Nakano Y; Ishikawa A; Kojima K; Li H; Shimada H; Kashiwado K; Mukai H; Horikoshi T; Sugiyama A; Uno T; Kuwabara S
    J Alzheimers Dis; 2020; 78(4):1639-1652. PubMed ID: 33185599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
    Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
    Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical parametric analysis of cerebral blood flow in vascular dementia with small-vessel disease using Tc-HMPAO SPECT.
    Kato H; Yoshikawa T; Oku N; Imaizumi M; Takasawa M; Kimura Y; Kajimoto K; Tanaka M; Kitagawa K; Hori M; Hatazawa J
    Cerebrovasc Dis; 2008; 26(5):556-62. PubMed ID: 18836267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.
    Kogure D; Matsuda H; Ohnishi T; Asada T; Uno M; Kunihiro T; Nakano S; Takasaki M
    J Nucl Med; 2000 Jul; 41(7):1155-62. PubMed ID: 10914904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging Characteristics of Frailty Status in Patients with Alzheimer's Disease.
    Hirose D; Shimizu S; Hirao K; Ogawa Y; Sato T; Kaneko Y; Takenoshita N; Namioka N; Fukasawa R; Umahara T; Sakurai H; Watanabe R; Hanyu H
    J Alzheimers Dis; 2019; 67(4):1201-1208. PubMed ID: 30689570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of both morphologic and functional changes in the same individuals with Alzheimer's disease.
    Matsuda H; Kitayama N; Ohnishi T; Asada T; Nakano S; Sakamoto S; Imabayashi E; Katoh A
    J Nucl Med; 2002 Mar; 43(3):304-11. PubMed ID: 11884488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superiority of 3-dimensional stereotactic surface projection analysis over visual inspection in discrimination of patients with very early Alzheimer's disease from controls using brain perfusion SPECT.
    Imabayashi E; Matsuda H; Asada T; Ohnishi T; Sakamoto S; Nakano S; Inoue T
    J Nucl Med; 2004 Sep; 45(9):1450-7. PubMed ID: 15347711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of SPM and NEUROSTAT in voxelwise statistical analysis of brain SPECT and MRI at the early stage of Alzheimer's disease.
    Nishimiya M; Matsuda H; Imabayashi E; Kuji I; Sato N
    Ann Nucl Med; 2008 Dec; 22(10):921-7. PubMed ID: 19142712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of brain perfusion SPECT in Alzheimer's disease using a fully automated regional cerebral blood flow quantification software, 3DSRT.
    Kobayashi S; Tateno M; Utsumi K; Takahashi A; Saitoh M; Morii H; Fujii K; Teraoka M
    J Neurol Sci; 2008 Jan; 264(1-2):27-33. PubMed ID: 17764699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral blood flow differences in patients with mild cognitive impairment between those who did and did not develop Alzheimer's disease.
    Park KW; Yoon HJ; Kang DY; Kim BC; Kim S; Kim JW
    Psychiatry Res; 2012; 203(2-3):201-6. PubMed ID: 22980226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.